2017 Pediatric Rheumatology Symposium

May 17-20, 2017 in Houston, Texas

View by Number View by Title View Sessions

View by Date

Abstract Number: 16

Novel Serum Broad-Based Proteomic Discovery Analysis Identifies Proteins and Pathways Dysregulated in Juvenile Dermatomyositis (JDM) Myositis Autoantibody Groups
Abstract Number: 17

Anti-endothelial cell antibodies in juvenile dermatomyositis
Abstract Number: 18

Bridging the gap between GWAS and mechanism in juvenile idiopathic arthritis using a novel high-throughput experimental screen
Abstract Number: 19

The Lymphocyte Repertoire in Juvenile Dermatomyositis
Abstract Number: 20

Enthesitis-Related Arthritis: Non-Peripheral Pattern is Associated with an Expansion of Peripheral Th17 Populations
Abstract Number: 21

Enhancing Quality of Care in Childhood-Onset Systemic Lupus Erythematosus by Improving Performance on Quality Indicator Measures in Cardiovascular and Bone Health
Abstract Number: 22

Patient perception of barriers to taking medication in Juvenile Idiopathic Arthritis
Abstract Number: 23

Impact of an Institutional Specialty Pharmacy on Adherence to Biologic Therapies
Abstract Number: 24

Development and Implementation of a “Data-In-Once” Model for a Pediatric Rheumatology Learning Health System
Abstract Number: 25

Reliability of the Physician Global Assessment Scores for Determination of Disease Activity Status within the Pediatric Rheumatology Care and Outcomes Improvement Network
Abstract Number: 26

Gray Matter Volume Loss in Youth with SLE
Abstract Number: 27

Assessing the Safety of Kidney Biopsies Performed on Childhood-onset Systemic Lupus Erythmatosus Patients
Abstract Number: 28

Dyslipidemia in Juvenile Dermatomyositis
Abstract Number: 29

Spinal Cord Inflammation in Children with Small Vessel Primary CNS Vasculitis
Abstract Number: 30

Cross-sectional Analysis of Depression and Medication Non-Adherence in Childhood-onset Systemic Lupus Erythematosus